Mammary Tumors of the Rat" a Review

Total Page:16

File Type:pdf, Size:1020Kb

Load more

CANCER RESEARCH VoLvm~ 19 DECEMBER 1959 NUMBER 11 Mammary Tumors of the Rat" A Review R. L. NOBLE AND J. H. CvT'rs (Dept. of Medical Research, Collip Laboratory, University of Western Ontario, London, Canada) Mammary tumors in the rat have been studied ORIGIN AND CHARACTERISTICS in detail by only a few groups of workers. There is, A. SPONTANEOUS MAMMARY TUMORS however, a considerable amount of information on 1. Incidence.--Spontaneous tumors in rats al- the subject contained in isolated papers and scat- lowed to live their normal life span are relatively tered throughout the scientific literature. Appar- common, and in large series of animals from 10 to ently, no previous attempt has been made to re- 60 per cent may show tumors of some kind (13, view this field of interest. In the past, the attention 119). The proportion of these which were confined of geneticists, virologists, endocrinologists, and to mammary tissue has varied in different reports biologists has been focused on the mammary tu- and with different strains of rats; however, mam- mors of the mouse, and a vast literature has ac- mary tumors have been the common type of tu- cumulated in which these tumors are characterized mor affecting the over-all tumor incidence. In the very exactly. The rat has been somewhat neglected August strain of rats 30 per cent of all tumors were in this concentration of effort on the smaller spe- of mammary origin, whereas in the Copenhagen cies, although it would appear worthy of greater strain only 5.6 per cent were similarly situated and more serious attention. The need for a tabula- (13). In another large series of rats of mixed tion of rat data may be appreciated from the ap- strains, 18 per cent of 521 spontaneous tumors pearance in 1954 of a paper in Science, containing were located in the breast (9). Of a group of 150 no references, entitled "Successful Transplanta- female Sprague-Dawley rats with an average life tion of an Apparently Benign Neoplasm." A rat span of 760 __+_21 days, mammary tumors ac- fibroadenoma apparently was transplanted suc- counted for 95 per cent of the total tumors found cessfully. This achievement should not have been and were present in 54 per cent of the animals. In a unexpected in view of Loeb's report in 1902 of group of 40 males, 12.5 per cent showed tumors of autotransplantation and in 1916 of homoiotrans- which only two were of mammary origin, giving a plantation of similar tumors in rats. general average of 88 per cent for both sexes. In Rat mammary tumors have many points of in- two colonies of rats of the Wistar strain mammary terest and differ from those of the mouse in many tumors accounted for 77 per cent of all tumors. In ways. Histologically, both benign and malignant females 281 of 839 (68 per cent) showed mammary tumors occur spontaneously in the rat, or may be tumors, whereas 42 of 129 males (32 per cent) had similar tumors (119). It is apparent that from 6 to induced by a number of means. No viral factors 77 per cent of all tumors occurring spontaneously have been demonstrated, and most rat tumors are in rats may be of the mammary gland and that curiously sensitive to hormone manipulation. females may show a ratio of approximately 6 to 1 Their possible value in chemotherapeutic screen- when compared with males. ing of hormone derivatives has only recently re- 2. Malignant tumors of epithelial or mesodermal ceived attention. All these considerations will be origin.--Malignant, spontaneous mammary tu- pointed out in the following review. mors in the rat have been classified as adenocar- Received for publication June 11, 1959. cinoma, solid carcinoma, cystadenocarcinoma, 1125 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 1959 American Association for Cancer Research. 11~6 Cancer Research Vol. 19, December, 1959 papillary carcinoma, and, rarely, squamous-cell mors. Similarly, Bullock and Curtis (9) examined carcinoma. Fibrosarcomas are more frequently en- 94 tumors of the breast and noted eight adenomas, countered, and mixed tumors combining adeno- one adenolipoma, and 78 fibroadenomas or fibro- carcinoma and squamous-cell cancer have been mas (93.4 per cent benign tumors). In 150 described. Thus, of 41 malignant spontaneous tu- Sprague-Dawley female rats, 90 per cent of 7~ mors encountered in a series of rats of mixed breast tumors were classed as benign--one adeno- strains, s per cent were classed as of epithelial ma, 46 adenofibromas, and eighteen fibromas (16). origin (seven adenocarcinoma, one squamous-cell Curtis, Bullock, and Dunning (13), after examin- carcinoma, and two adeno-acanthoma), 12 per ing over 30,000 rats from seven distinct strains, cent as mixed tumors (three sarcoma with adeno- found a total tumor incidence of 9.6 per cent, and, carcinoma and two with added squamous-cell car- of these, mammary fibroadenoma contributed cinoma), and 59 per cent as fibrosarcoma (28). 12.8 per cent. Of the 6410 female rats reaching an Bullock and Curtis (9), in examining 94 spontane- age of 14 months (considered to be the minimum ous breast tumors occurring in 489 rats of mixed time of appearance), 0.9 per cent showed benign origin, noted two cystadenocarcinoma with squa- fibroadenomas. Of 219 female Wistar rats bearing mous epithelium, two carcinosarcomas, and three mammary tumors and averaging 650 days of age, adenomas exhibiting sarcomatous change. Dun- 206 were classed as benign tumors. The growth ning and Curtis (23), in a study of 15,625 rats de- rate of the spontaneous fibroadenomas varied rived from twenty generations of pure strain Co- greatly. Of twenty tumors, eleven increased 2-10 penhagen 2331 and Fischer 344 rats and their times their original volume in 90 days (119). reciprocal F1 and backcross hybrids, also observed Metastases have not been observed. 82 mammary tumors. Of these, only two were 4. Factors influencing incidence of spontaneous malignant: one was an adenocarcinoma and one a tumors.- fibrosarcoma. Age: The age of the rat, as might be sus- In 149 mammary tumors arising in random- pected, influences the incidence of spontaneous tu- bred Albany strain of hooded rats, only one adeno- mors found at any time. Studies in which the ani- carcinoma was found (8, 144). In 468 rats of mals have been allowed to live their normal life Wistar origin exhibiting 273 mammary tumors, span have been the most informative. It was noted eleven mammary adenocarcinomas and two sar- that 80 per cent of fibroadenomas developed in comas were noted (119). Similarly, of 94 spontane- female Wistar rats between 64 and 128 weeks of ous tumors of the breast occurring in 489 rats only age, whereas carcinomas occurred somewhat ear- two were classed as cystadenocarcinoma and two lier in life (119). In the Albany strain of rats, be- as carcinosarcoma (9). Probably the highest inci- nign tumors arose chiefly between 52 and 88 weeks dence of spontaneous adenocarcinoma of the of age, although three tumors were noted in rats breast has been reported in 150 female rats of the only 20 weeks of age (144). In a comparison of Sprague-Dawley random-bred strain. Over an seven different strains of rats, fibroadenomas were average life span of 760 + 21 days, mammary tu- encountered in 0.9 per cent of 6410 females reach- mors were found in 72 rats (54 per cent) and, of ing 14 months of age (13). these, seven (10 per cent) were classed as adeno- Sex: As may be noted from the preceding dis- carcinoma. The over-all incidence of carcinoma of cussion, the sex of the rat may markedly influence the breast in these female rats therefore was 4.6 the occurrence of mammary tumors. Female ani- per cent. On the other hand, a smaller group of 40 mals were much more predisposed to this type of male animals of the same strain developed only tumor, although all types of tumors have been en- two mammary tumors (16). Metastases from spon- countered in males. The relative frequency of taneous malignant tumors have occasionally been mammary tumors has been low in males, possibly noted (8, 28). from 1 to 6 per cent of all mammary tumors. 3. Benign tumors of epithelial or mesodermal While exact experiments are not available, the origin.--Benign spontaneous mammary tumors implication is strong that the cause of the higher constitute a much larger group than do the preced- incidence in females is related to the influence of ing. Adenoma and adenolipoma have been de- the sex hormones. As will be seen later, estrogens scribed occasionally, but fibroadenoma and fibro- and progesterone may stimulate growth or be es- ma are apparently the most common tumor. Of the sential for successful takes of transplanted spon- 82 mammary tumors found in 15,625 rats pre- taneous mammary tumors, particularly the fibro- viously referred to (I~8), two were adenomas, two adenomas. On the other hand, it may be noted that adenolipomas, five fibromas, and 21 fibroadenomas mammary tumors induced by sex hormones are ba total of 93.7 per cent benign mammary tu- usually multiple, and practically all are classed as Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 1959 American Association for Cancer Research. NOBLE AND CuTTs--Mammary Tumors of the Rat: Review 1127 carcinoma. Some of the earlier workers were im- has been described as being discovered in 1938 on pressed with the possible role of a disturbed hor- the lower abdomen of a pregnant albino rat. It ap- mone balance as a cause of spontaneous tumors in parently regressed in size during lactation but the rat (70, 96) and believed that forced breeding grew rapidly again after the young were weaned.
Recommended publications
  • Proceedings of the Thirtieth Annual Meeting of the American Society for Clinical Investigation Held in Atlantic City, N

    Proceedings of the Thirtieth Annual Meeting of the American Society for Clinical Investigation Held in Atlantic City, N

    PROCEEDINGS OF THE THIRTIETH ANNUAL MEETING OF THE AMERICAN SOCIETY FOR CLINICAL INVESTIGATION HELD IN ATLANTIC CITY, N. J., MAY 2, 1938 J Clin Invest. 1938;17(4):501-537. https://doi.org/10.1172/JCI100977. Research Article Find the latest version: https://jci.me/100977/pdf PROCEEDINGS OF THE THIRTIETH ANNUAL MEETING OF THE AMERICAN SOCIETY FOR CLINICAL INVESTIGATION HELD IN ATLANTIC CITY, N. J., MAY 2, 1938 READ BEFORE THE SCIENTIFIC SESSION The Successful Treatment of Pernicious Anemia by in powdered form hemostasis was readily obtained in Means of Non-Autolyzed Yeast. By MAXWELL M. hemorrhages following nine dental extractions and three WINTROBE, Baltimore, Md. external wounds in five hemophilic subjects. When ap- It has been the general opinion that yeast, if it pos- plied in liquid form as other hemostatics are usually em- sesses any antianemic potency whatever, is effective only 1 loyed the results were unsatisfactory. Since the co- after autolysis and then only by virtue of its content of agulation time of the circulating blood was unchanged the "extrinsic factor." The observations reported contradict effectiveness of powdered beef globulin substance when this view and indicate that dehydrated yeast which has locally applied to a bleeding wound in hemophilia is not been subjected to autolysis, contains an antiper- attributed to the rapid formation of a firm fibrin clot. nicious anemia substance. Yeast obtained from two dif- The failure of liquid preparations may be due to the ferent sources was effective in the treatment of classical inability to maintain a sufficient concentration of the cases of pernicious anemia.
  • Materializing Estrogen and Regulation Under Canada's Food and Drugs Act, 1939-1953 Lara Jessie Tessaro

    Materializing Estrogen and Regulation Under Canada's Food and Drugs Act, 1939-1953 Lara Jessie Tessaro

    Osgoode Hall Law School of York University Osgoode Digital Commons LLM Theses Theses and Dissertations 8-27-2018 Toxic Enactments: Materializing Estrogen and Regulation Under Canada's Food and Drugs Act, 1939-1953 Lara Jessie Tessaro Follow this and additional works at: https://digitalcommons.osgoode.yorku.ca/llm Part of the Legal History Commons TOXIC ENACTMENTS: MATERIALIZING ESTROGEN AND REGULATION UNDER CANADA’S FOOD AND DRUGS ACT, 1939-1953 LARA TESSARO A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF LAWS GRADUATE PROGRAM IN LAW OSGOODE HALL LAW SCHOOL, YORK UNIVERSITY TORONTO, ONTARIO August 2018 © Lara Tessaro, 2018 ABSTRACT The study describes how estrogen was standardized in Canada, in the 1940s and early 1950s, under the Food and Drugs Act. Contributing to interdisciplinary conversations, it provides an empirical case of how regulatory practices enact material realities. Using archival material, the study describes how estrogen was achieved, in part, through heterogeneous practices of the Canadian Committee on Pharmacopoeial Standards, National Health, and government solicitors. These regulators disagreed on whether, how, and by whom estrogens should be standardized. Rather than resolve these disagreements, Canada enacted multiple regulations purporting to standardize estrogen, and government solicitors practiced “techniques of validating” to render the regulations as lawful. I argue that these regulatory enactments materialized estrogen as a potent, unpredictable, and multiple object. Further, I show how estrogen spawned novel regulatory techniques in Canada, particularly the use of consumer product labels. In this way, estrogen catalyzed an early example of risk regulation in Canada.
  • Patent Office

    Patent Office

    UNITED STATES 2,233,025PATENT OFFICE ESTRADIO-1-MONOESTERS Karl Miescher, Riehen, and Caesar Scholz, Basel, Switzerland, assignors, by mesne assignments, to Ciba, Pharmaceutical Products, Incorporated, Summit, N.J., a corporation of New Jersey No Drawing. Application October 7, 1937, Serial No. 167,866. In Switzerland November 20, 1936 4 Claims. (CI. 260-397) This invention is based on the surprising ob servation that partially esterified compounds of ually passes into solution. This solution is acidi the dihydro-estrin series having a free phenolic fied and a precipitate is produced by the addi hydroxyl are obtained when completely esterified tion of 200 parts of water. This is filtered and 5 compounds of the dihydro-estrin series are treat Washed Successively with water, dilute sodium ed in careful manner with hydrolytically acting carbonate Solution and again with water. The agents. In this way only those acid residues are estradiol-17-mono-propionate which is already split off which are bound at the phenolic hy Very pure can be recrystallized from a mixture O droxyl-groups. of methyl alcohol and water. It melts at As hydrolytically acting agents there may be 199-200° C. used both those of an alkaline nature and those The time necessary for the reaction depends of an acid nature. Suitable alkaline agents are, on the temperature and the degree of dilution for example alkali hydroxides, alkali carbonates, used. 5. alkaline earth hydroxides, magnesia or the like. Eacample 2 As acid reagents hydrogen halide acids, Sulfuric A solution of 1 part of estradiol-3:17-dipro acid, phosphoric acid or the like may be used.
  • Antiviral Drug

    Antiviral Drug

    Suraj Punj Journal For Multidisciplinary Research ISSN NO: 2394-2886 Vibrational spectra of 1- methylestin-3 thosomicarbozole (methisazole): Antiviral Drug Dr. DB Singh*, Kiran Pandey, Pragya Singh, Deepali Singh, Madhusmita Singh, DEEPIKA NISHAD Micro molecular and Bio physics Laboratory; Department Of Physics; DSMNR University; Lucknow. Abstract: 1-methylestin-3 thosomicarbozole (methisazole) is a chemical compound that shows the property of Antiviral Drug. A complete assignment of fundamental vibration frequencies has been made, and the spectra have been interpreted in detail. The non-planar frequencies have been calculated with the aid of force constants determined for related molecules. The fundamental vibrational frequencies and intensity of vibrational bands were evaluated using density functional theory (DFT) using standard B3LYP/6-31G methods and basis set combinations. The optimized geometric structure of 1- methylestin-3 thosomicarbozole (methisazole) has been studied by using Density Functional Theory (DFT). On the basis of ground and excited state geometries, the absorption spectra have been calculated using the DFT method. To understand the Non-Linear Optical properties of 1- methylestin-3 thosomicarbozole (methisazole), we computed dipole moment (μ) ,using B3LYP density functional theory method in conjunction with 6-31G basis set. Keywords: FTIR, FT-Raman, DFT, HOMO, LUMO, Vibrational spectra, antiviral. Volume 9, Issue 4, 2019 Page No: 31 Suraj Punj Journal For Multidisciplinary Research ISSN NO: 2394-2886 Introduction: 1-methylestin-3 thosomicarbozole (methisazole) is a chemical compound that shows the property of Antiviral Drug. The optimized geometrical compound of antiviral activity, this antiviral drug design is to identify viral proteins, or parts of proteins, that can be disabled.
  • UNITED STATES PATENT OFFICE 2,231,017 ALLO-PREGNANE COMPOUNDS and METH OD of OBTAINING the SAME Russell Earl Marker, State

    UNITED STATES PATENT OFFICE 2,231,017 ALLO-PREGNANE COMPOUNDS and METH OD of OBTAINING the SAME Russell Earl Marker, State

    Patented Feb. 11, 1941 2,231,017 UNITED STATES PATENT OFFICE 2,231,017 ALLO-PREGNANE COMPOUNDS AND METH OD OF OBTAINING THE SAME Russell Earl Marker, State. College, Pa., assignor to Parke, Davis & Company, Detroit, Mich., a corporation of Michigan No Drawing. Application March 12, 1937, Serial No. 130,582 6 Claims. (CI. 260-397) The invention relates to a new keto-alcohol of with a ketone reagent capable of reacting with the sterol series, and particularly to epi-allo the epi-allo-pregnane-ol- (3)-one- (20) but not pregnanol- (3)-One- (20) and its isolation from with the non-ketonic alcohols. mixtures with other sterol derivatives of a non 7. Separating the reaction product of step (6) 5 ketonic nature. from non-ketonic alcohols, and, It is known that the two non-ketonic alcohols 8. Decomposing the reaction product to obtain having a cyclopentano-10,13-dimethyl polyhy epi-allo-pregnane-ol- (3) -one- (20), which can drophenanthrene nucleus, pregnanediol and allo be readily separated by means of Organic Sol pregnanediol, belonging to the pregnane or pro vents from the decomposition products of this O gesterOne chemical group, may be isolated from Step. O the neutral or alcoholic fraction of human preg . The above series of eight steps is of Special nancy urine. However, no compounds of a keton value when the original mixture to be treated ic nature have been heretofore isolated from is a neutral carbinol fraction from human preg these or other like mixtures. nancy urine. In step (6) above the use of a It is an object of the invention to separate hydrazine compound capable of forming a and isolate the new ketonic alcohol, epi-allo water-soluble hydrazine derivative With the epi 5 pregnanol- (3)-One- (20), from its mixtures with allo-pregnanol- (3)-one- (20) is preferred as a pregnanediol and allo-pregnanediol or other like ketone reagent.
  • Trabajo Final De Máster Profesional

    Trabajo Final De Máster Profesional

    TRABAJO FINAL DE MÁSTER PROFESIONAL MÁSTER UNVIERSITARIO EN TRADUCCIÓN MÉDICO-SANITARIA DEPARTAMENTO DE TRADUCCIÓN Y COMUNICACIÓN Curso académico 2013-2014 (Julio, 2014) BLANCA HERNÁNDEZ PARDO 1 2 En Egipto, a las bibliotecas se las denominaba «tesoro de los remedios del alma». En efecto, curábase en ellas la ignorancia, la más peligrosa de las enfermedades y origen de todas las demás. Jacques Benigne Bousset 3 ÍNDICE DE CONTENIDOS Conclusiones del trabajo 5 1. Introducción 6 1.1. Síntesis de los contenidos y ubicación temática 6 1.2. Género textual y situación comunicativa 8 1.3. Resumen comparativo del TO y el TM 11 1.4. Consideraciones sobre aspectos específicos del encargo 12 2. Texto origen y texto meta 13 2.1. Documento – capítulo 25 13 2.2. Documento – preguntas y respuestas del capítulo 25 18 2.3. Documento – capítulo 26 20 2.4. Documento – preguntas y respuestas del capítulo 26 26 3. Comentario de traducción 28 3.1. Metodología 28 3.2. Problemas de traducción 32 3.2.1. Dificultades terminológicas 32 3.2.2. Dificultades de estilo fraseológico 44 3.2.3. Dificultades culturales 57 3.3 Resumen de las dificultades de traducción 60 4. Glosario e investigación terminológica 61 4.1. Glosario terminológico 63 4.2. Análisis terminológico del equipo de investigación 121 5. Textos paralelos 136 6. Recursos y herramientas 138 7. Bibliografía 143 4 CONCLUSIONES DEL TRABAJO El presente trabajo se ha realizado con la finalidad de plasmar de forma desarrollada el proceso traductológico llevado a cabo a lo largo de las prácticas de traducción como parte del máster universitario en Traducción Médico-Sanitaria de la Universitat Jaume I.
  • Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy

    Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy

    International Journal of Molecular Sciences Review Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy Jin Bai 1 , Qian-Rong Qi 1 , Yan Li 1, Robert Day 1, Josh Makhoul 1 , Ronald R. Magness 2 and Dong-bao Chen 1,* 1 Department of Obstetrics & Gynecology, University of California, Irvine, CA 92697, USA; [email protected] (J.B.); [email protected] (Q.-R.Q.); [email protected] (Y.L.); [email protected] (R.D.); [email protected] (J.M.) 2 Department of Obstetrics & Gynecology, University of South Florida, Tampa, FL 33612, USA; [email protected] * Correspondence: [email protected]; Tel.: +949-824-2409 Received: 27 May 2020; Accepted: 15 June 2020; Published: 18 June 2020 Abstract: Normal pregnancy is associated with dramatic increases in uterine blood flow to facilitate the bidirectional maternal–fetal exchanges of respiratory gases and to provide sole nutrient support for fetal growth and survival. The mechanism(s) underlying pregnancy-associated uterine vasodilation remain incompletely understood, but this is associated with elevated estrogens, which stimulate specific estrogen receptor (ER)-dependent vasodilator production in the uterine artery (UA). The classical ERs (ERα and ERβ) and the plasma-bound G protein-coupled ER (GPR30/GPER) are expressed in UA endothelial cells and smooth muscle cells, mediating the vasodilatory effects of estrogens through genomic and/or nongenomic pathways that are likely epigenetically modified. The activation of these three ERs by estrogens enhances the endothelial production of nitric oxide (NO), which has been shown to play a key role in uterine vasodilation during pregnancy. However, the local blockade of NO biosynthesis only partially attenuates estrogen-induced and pregnancy-associated uterine vasodilation, suggesting that mechanisms other than NO exist to mediate uterine vasodilation.
  • 022501Orig1s000

    022501Orig1s000

    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022501Orig1s000 PROPRIETARY NAME REVIEW(S) Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Date: October 8, 2010 Application Type/Number: NDA 022501 To: Scott Monroe, M.D., Director Division of Reproductive and Urologic Products Through: Zachary Oleszczuk, Pharm.D., Team Leader Denise Toyer, Pharm.D., Deputy Director Division of Medication Error Prevention and Analysis From: Tara Turner, Pharm.D., Safety Evaluator Division of Medication Error Prevention and Analysis Subject: Proprietary Name, Label and Labeling Review Drug Name(s): Lo Loestrin Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, 1 mg/10 mcg Ethinyl Estradiol Tablets, 10 mcg and Ferrous Fumarate Tablets, 75 mg) Applicant: Warner Chilcott OSE RCM #: 2010-1184 and 2009-652 CONTENTS 1 INTRODUCTION................................................................................................................... 3 2 METHODS AND RESULTS.................................................................................................. 3 2.1 Proprietary Name ........................................................................................................... 3 2.2 Labels and Labeling....................................................................................................... 3 3 DISCUSSION ........................................................................................................................
  • 2019 Table of Drugs

    2019 Table of Drugs

    2019 Table of Drugs Questions regarding coding and billing guidance should be submitted to the insurer in whose jurisdiction a claim would be filed. For private sector health insurance systems, please contact the individual private insurance entity. For Medicaid systems, please contact the Medicaid Agency in the state in which the claim is being filed. For Medicare, contact the Medicare contractor. IA - Intra-arterial administration IV - Intravenous administration IM - Intramuscular administration IT - Intrathecal SC - Subcutaneous administration INH - Administration by inhaled solution VAR - Various routes of administration OTH - Other routes of administration ORAL - Administered orally Intravenous administration includes all methods, such as gravity infusion, injections, and timed pushes. The ‘VAR’ posting denotes various routes of administration and is used for drugs that are commonly administered into joints, cavities, tissues, or topical applications, in addition to other parenteral administrations. Listings posted with ‘OTH’ indicate other administration methods, such as suppositories or catheter injections. A Abatacept 10 mg IV J0129 Abbokinase, see Urokinase Abbokinase, Open Cath, see Urokinase Abciximab 10 mg IV J0130 Abelcet, see Amphotericin B Lipid Complex ABLC, see Amphotericin B AbobotulinumtoxintypeA 5 units IM J0586 Acetaminophen 10 mg IV J0131 Acetazolamide sodium up to 500 mg IM, IV J1120 Acetylcysteine, IVection 100 mg IV J0132 Acetylcysteine, unit dose form per gram INH J7604, J7608 1 Achromycin, see Tetracycline Actemra,
  • Feto-Placental Steroids and Parturition in the Ewe Frederick Nimrod Thompson Jr

    Feto-Placental Steroids and Parturition in the Ewe Frederick Nimrod Thompson Jr

    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1973 Feto-placental steroids and parturition in the ewe Frederick Nimrod Thompson Jr. Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Animal Sciences Commons, Physiology Commons, and the Veterinary Physiology Commons Recommended Citation Thompson, Frederick Nimrod Jr., "Feto-placental steroids and parturition in the ewe " (1973). Retrospective Theses and Dissertations. 5054. https://lib.dr.iastate.edu/rtd/5054 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORMATION TO USERS This material was produced from a microfilm copy of the original document. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the original submitted. The following explanation of techniques is provided to help you understand markings or patterns which may appear on this reproduction. 1.The sign or "target" for pages apparently lacking from the document photographed is "Missing Page(s)". If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting thru an image and duplicating adjacent pages to insure you complete continuity. 2. When an image on the film is obliterated with a large round black mark, it is an indication that the photographer suspected that the copy may have moved during exposure and thus cause a blurred image.
  • Neurosteroids As Novel Antidepressants and Anxiolytics: GABA-A Receptors and Beyond

    Washington University School of Medicine Digital Commons@Becker Open Access Publications 11-1-2019 Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond Charles F Zorumski Steven M Paul Douglas F Covey Steven Mennerick Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Neurobiology of Stress 11 (2019) 100196 Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: www.elsevier.com/locate/ynstr Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond T ∗ Charles F. Zorumskia,b,e, , Steven M. Paula,c,e, Douglas F. Coveya,d,e, Steven Mennericka,b,e a Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA b Department of Neuroscience, Washington University School of Medicine, St. Louis, MO, USA c Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA d Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA e The Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, USA ARTICLE INFO ABSTRACT Keywords: The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a treatment for women with Allopregnanolone postpartum depression, and successful trials of a related neuroactive steroid, SGE-217, for men and women with Brexanolone major depressive disorder offer the hope of a new era in treating mood and anxiety disorders based on the SGE-217 potential of neurosteroids as modulators of brain function. This review considers potential mechanisms con- Steroid enantiomers tributing to antidepressant and anxiolytic effects of allopregnanolone and other GABAergic neurosteroids fo- Tonic inhibition cusing on their actions as positive allosteric modulators of GABAA receptors.
  • Chemical Study on Estrogens

    Ministerie van Verkeer en Waterstaat Directoraat-Generaal Rijkswaterstaat Rijksinstituut voor Kust en Zee/RIKZ Chemical study on estrogens Report: RIKZ/2001.028 1 juli 2001 Authors: BKH Consulting Engineers drs. P.C. Okkerman drs. C.P. Groshart RIKZ drs. A.M.C.M. Pijnenburg BKH Consulting Engineers P.O. Box 5094 2600 GB Delft Tel. 31 15 2625299 Fax 31 15 1619326 RIKZ Kortenaerkade 1 P.O. Box 20907 2500 EX Den Haag Tel. 31 70 3114311 Fax 31 70 3114330 _____________________________________ Chemical study on estrogens 1 _____________________________________ Chemical study on estrogens 2 Contents . .. Preface 5 Summary 6 1 Introduction 12 1.1 Backgrounds 12 1.2 Objectives 12 1.3 Limitations 13 2 Physical chemical properties 14 2.1 Identification 14 2.1.1 Oestradiols 15 2.1.2 Oestrone 16 2.1.3 Ethinyl-oestradiol 16 2.2 Physico-chemical characterisation 17 2.2.1 Oestradiols 17 2.2.2 Oestrone 18 2.2.3 Ethinyloestradiol 18 2.3 References 19 3 PRODUCTION AND USE 20 3.1 Uses 20 3.1.1 Natural estrogens 20 3.1.2 Synthetic estrogens 20 3.1.3 Veterinary use 21 3.2 Major producers 21 3.3 Production processes 22 3.3.1 Synthesis of 17ß-Oestradiol and oestrone 22 3.3.2 Synthesis of ethinyloestradiol 23 3.3.3 Wastewater treatment 24 3.4 Demands and developments 25 3.5 Conclusions and recommendations 25 3.6 References 25 4 Emissions to aquatic environment 29 4.1 Emission routes 27 4.2 Emission of natural hormones of human and animal origin 28 4.2.1 Cattle 28 4.2.2 Pigs 30 4.2.3 Chickens 32 4.2.4 Horses 33 4.2.5 Total animal emission through excretion 33